Ultragenyx Pharmaceutical
Kateryna Krygan, MSF, is an experienced corporate real estate professional currently serving as the Director of Corporate Real Estate at Ultragenyx since April 2021. In this role, Kateryna develops and executes strategic real estate initiatives to enhance company operations and shareholder value. Prior to Ultragenyx, Kateryna worked at EY as a Strategy & Transformation Senior, providing real estate and workplace strategic initiatives to clients. Earlier experience includes positions at CBRE, where Kateryna managed global portfolio strategies, and at JLL, where Kateryna supported transaction management for a significant global account. Kateryna holds a Master’s Degree in Finance from Florida International University and a Bachelor’s Degree in Linguistics from Yuriy Fedkovych Chernivtsi National University.
This person is not in any teams
This person is not in any offices
Ultragenyx Pharmaceutical
11 followers
Ultragenyx is a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases.